Tori is a real patient treated with ZORYVE cream 0.15%. Stella is a real patient treated with ZORYVE cream 0.15% and ZORYVE foam 0.3%. Both were compensated for their time spent sharing their experience. Individual results may vary.
ZORYVE cream 0.15% is strongly recommended as a treatment option for adults with mild to moderate eczema (atopic dermatitis) by the American Academy of Dermatology 2025 guidelines.
Award-winning Eczema Treatment ZORYVE cream 0.15% for for mild to moderate eczema (atopic dermatitis) ages 6+
Allure award-winner: ZORYVE cream 0.15% and 0.3%
ZORYVE foam 0.3%
First topical prescription medication recognized by the National Psoriasis Foundation* ZORYVE cream 0.3% and foam 0.3%
*For more information about the National Psoriasis Foundation Seal of Recognition, please go to psoriasis.org/seal-of-recognition-program/
ZORYVE Direct Savings Card
Eligible patients with commercial drug insurance may pay as little as $0 for ZORYVE†
†Subject to eligibility criteria and maximum program limitation. This offer is not valid for patients without commercial drug insurance or whose prescription claims are eligible to be reimbursed, in whole or in part, by any government program. Terms and Conditions may be viewed here.
